Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
20
EGRX Quote, Financials, Valuation and Earnings
Last price:
$1.20
Seasonality move
:
11.64%
Day range:
$1.10 - $1.48
52-week range:
$0.00 - $6.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
0.06x
Volume:
46.2K
Avg. volume:
7.3K
1-year change:
-74.84%
Market cap:
$15.6M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for EGRX
May 15
2025
Most recent earnings per share
$0.39
Missed by $0.75
(Aug 8/2023)
Consensus Estimate
$1.14
(Aug 8/2023)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EGRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/13/2024 | Q4 | -- | -- | -- | $1.07 | -- |
| 11/09/2023 | Q3 | -- | -- | -- | $1.09 | -- |
| 08/08/2023 | Q2 | -- | -- | $0.39 | $1.14 | -$0.75 |
| 05/09/2023 | Q1 | -- | -- | $0.44 | $1.05 | -$0.61 |
| 03/13/2023 | Q4 | -- | -- | $0.62 | $0.83 | -$0.21 |
| 11/07/2022 | Q3 | -- | -- | -$0.54 | $0.91 | -$1.45 |
| 08/09/2022 | Q2 | -- | -- | -$0.74 | $3.36 | -$4.10 |
| 05/09/2022 | Q1 | -- | -- | $3.41 | $3.66 | -$0.25 |
| 03/07/2022 | Q4 | -- | -- | -$0.48 | $0.94 | -$1.42 |
| 11/09/2021 | Q3 | -- | -- | -$0.43 | $0.83 | -$1.26 |
| 08/09/2021 | Q2 | -- | -- | $0.27 | $0.80 | -$0.53 |
| 05/10/2021 | Q1 | -- | -- | -$0.03 | $0.73 | -$0.76 |
| 03/02/2021 | Q4 | -- | -- | $0.59 | -$0.20 | $0.79 |
| 11/02/2020 | Q3 | -- | -- | $0.51 | $0.30 | $0.22 |
| 08/10/2020 | Q2 | -- | -- | -$0.02 | $0.24 | -$0.26 |
| 05/11/2020 | Q1 | -- | -- | -$0.21 | $0.57 | -$0.78 |
| 03/02/2020 | Q4 | -- | -- | $0.07 | $0.49 | -$0.42 |
| 11/12/2019 | Q3 | -- | -- | -$0.17 | $0.43 | -$0.60 |
| 08/08/2019 | Q2 | -- | -- | $0.48 | $0.83 | -$0.35 |
| 05/07/2019 | Q1 | -- | -- | $0.62 | $0.73 | -$0.11 |
| 02/28/2019 | Q4 | -- | -- | $0.86 | -- | -- |
| 11/01/2018 | Q3 | -- | -- | $0.91 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | $0.17 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | $0.17 | -- | -- |
| 02/26/2018 | Q4 | -- | -- | $0.58 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | $0.98 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | $0.28 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | $1.42 | -- | -- |
| 03/01/2017 | Q4 | -- | -- | $3.52 | -- | -- |
| 11/09/2016 | Q3 | -- | -- | $0.73 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | $0.80 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.06 | -- | -- |
| 02/25/2016 | Q4 | -- | -- | $0.07 | -- | -- |
| 11/11/2015 | Q3 | -- | -- | -$0.65 | -- | -- |
| 08/11/2015 | Q2 | -- | -- | -$0.53 | -- | -- |
Eagle Pharmaceuticals Earnings Questions
-
How Much did Eagle Pharmaceuticals Generate in Revenue Last Quarter?
Eagle Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Eagle Pharmaceuticals Beat Earnings Last Quarter?
Eagle Pharmaceuticals announced earnings per share of $0.39 which represents a miss of analyst forecast a $1.14 per share.
-
Is Eagle Pharmaceuticals Profitable?
Eagle Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Eagle Pharmaceuticals EPS Next Year?
Eagle Pharmaceuticals's earnings are forecast to grow from -- per share to $4.42 per share next year representing an increase of 71.8%.
-
When is Eagle Pharmaceuticals's Earnings Date?
Eagle Pharmaceuticals's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
